-
innovative research in the laboratory, in patients and in populations. BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise
-
of murine models of high-grade lymphoma with the aim of providing pre-clinical evidence to support the development of metabolic inhibitors as novel treatments for lymphoma, alone or in combination with
-
, QMUL. The Institute comprises approximately 350 staff based in four academic Centres and one Public Engagement Centre and supports a combined total of c750 postgraduate research and taught students
-
Vitro Models. The project aims to use organ-on-a-chip technology combined with bioengineering approaches to develop, validate and use a suite of vascularised human tendon-chip models. These high quality
-
of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. BCI is internationally renowned in many areas of cancer research, and it combines ground